ADAD (Huaizhong Health Group) YoY EBITDA Growth: 0.00% (As of Jan. 2023)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ADAD Huaizhong Health Group Inc ADAD
34 GF Score
Price $0.00
View Full Analysis

What is Huaizhong Health Group YoY EBITDA Growth?

Huaizhong Health Group ADAD 34 YoY EBITDA Growth is 0.00% as of Jan. 2023. GuruFocus rates ADAD with a GF Score™ of 34/100.

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Huaizhong Health Group's YoY EBITDA Growth for the quarter that ended in Jan. 2023 was 0.00%.

Huaizhong Health Group's EBITDA per Share for the three months ended in Jan. 2023 was $0.00.


Huaizhong Health Group YoY EBITDA Growth Historical Data

* Premium members only.

The historical data trend for Huaizhong Health Group's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Huaizhong Health Group YoY EBITDA Growth Chart

Huaizhong Health Group Annual Data
Trend Oct13 Oct14 Oct15 Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 100.66 -10,300.00 99.26 66.67 0.00

Huaizhong Health Group Quarterly Data
Apr18 Jul18 Oct18 Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
ADAD
34GF Score
Huaizhong Health Group Inc ADAD
YoY EBITDA Growth is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Huaizhong Health Group YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Huaizhong Health Group's YoY EBITDA Growth for the fiscal year that ended in Oct. 2022 is calculated as:

YoY EBITDA Growth (A: Oct. 2022 )
=(EBITDA per Share (A: Oct. 2022 )-EBITDA per Share (A: Oct. 2021 ))/ | EBITDA per Share (A: Oct. 2021 ) |
=(-0.001--0.001)/ | -0.001 |
=0.00 %

Huaizhong Health Group's YoY EBITDA Growth for the quarter that ended in Jan. 2023 is calculated as:

YoY EBITDA Growth (Q: Jan. 2023 )
=(EBITDA per Share (Q: Jan. 2023 )-EBITDA per Share (Q: Jan. 2022 )) / | EBITDA per Share (Q: Jan. 2022 )) |
=(-0--0)/ | -0 |
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about YoY EBITDA Growth →
What does a YoY EBITDA Growth of 0.00% mean?
Huaizhong Health Group (ADAD) has a YoY EBITDA Growth of 0.00% as of Jan. 2023. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for Huaizhong Health Group and its competitors.
Is Huaizhong Health Group's YoY EBITDA Growth too high?
Huaizhong Health Group's current YoY EBITDA Growth is 0.00%. Overall, Huaizhong Health Group has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.
How does Huaizhong Health Group's YoY EBITDA Growth compare to AMRR and NLSC?
Huaizhong Health Group's YoY EBITDA Growth of 0.00% can be compared against companies in the Diversified Financial Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good YoY EBITDA Growth for a Diversified Financial Services company?
A good YoY EBITDA Growth depends on the Diversified Financial Services industry context. However, YoY EBITDA Growth should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high YoY EBITDA Growth mean?
A high YoY EBITDA Growth can signal that a stock is expensive relative to its fundamentals. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for Huaizhong Health Group and its competitors. Huaizhong Health Group's current YoY EBITDA Growth is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Huaizhong Health Group stock overvalued right now?
Huaizhong Health Group (ADAD) has a current YoY EBITDA Growth of 0.00%. The current YoY EBITDA Growth is 0.00%. Huaizhong Health Group's overall GF Score™ is 34/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is YoY EBITDA Growth calculated?
YoY EBITDA Growth is calculated from a company's financial statements. For Huaizhong Health Group (ADAD), the current YoY EBITDA Growth is 0.00% as of Jan. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Huaizhong Health Group Business Description

Address 555 Panyu North Avenue, 13th Floor, Headquarters Center Building 16, Tianan Technology Park, Panyu District, Guangzhou, CHN, 523857
Huaizhong Health Group Inc is a shell company. It is, however, seeking to identify, locate, and, if warranted, acquire new commercial opportunities.
34GF Score

Get the complete analysis for ADAD

YoY EBITDA Growth is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price